Also, AZD8055 dose-dependently inhibited activation of the mTOR downstream targets, i.e., p-4EBP1 and p-S6, in both SCLC and NHBE cells indicating a desired on-target effect (Fig. 3c, d). This evidence concerns the gene MTOR and small cell lung carcinoma.